Key points are not available for this paper at this time.
No takes yet. Share an insight, caveat, or question.
Small single-centre data leave net benefit of antihypertensives in elderly uncertain; supports dedicated RCTs to clarify risk-benefit balance.
Anthony Jones (1982) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: